Meeting Program 2017

(Preliminary schedule, may be subject to change)

Wednesday, February 8th, 2017

AM
6:00 – 6:50
6:50 – 7:00
Breakfast with Exhibitors
Welcome Announcements
7:00 – 7:20 Surgical Management of BPH – Jaspreet Sandhu
7:20 – 7:40 Evidence Based Review of Risks and Benefits of Testosterone Supplementation – Landon Trost
7:40 – 8:00 Evaluation and Management of Mixed Incontinence – Kathleen C. Kobashi
8:00 – 8:20 Endoscopic Management of Ureteral Strictures – Thomas Jarrett
8:20 – 8:40 Break with Exhibitors
8:40 – 9:00 Should Collagenase Clostridium Histolyticum be Considered 1st Line Therapy for Peyronie’s Disease? – Landon Trost
9:00 – 9:20 Optimizing Outcomes with BPH Treatment – Jaspreet Sandhu
9:20 – 9:40 Mesh: What are the Alternatives? – Kathleen C. Kobashi
9:40 – 10:00 Embracing Innovative Medical Technologies to Improve Patient Consultation – Salim Hawatmeh
10:00 –11:00 Affordable Care Act: Political and Socio-Economic Landscape – Fernando J. Kim
11:00 – 3:30 Group Discussion “Ad Lib”
3:30 – 4:00 Après ski with Exhibitors
4:00 – 4:20 Am I “Bipolar” About Treating LUTS/BPH? – Kevin T. McVary
4:20 – 4:40 Imaging Simulation Prior to Partial Nephrectomy – Aurus Dourado Meneses
4:40 – 7:40

Critique Panel Discussion

Thursday, February 9th, 2017

AM
6:00 – 7:00 Breakfast with Exhibitors
7:00 – 7:20 Urology and Comparative Effectiveness Research: Is the Cart Before the Horse? – Will Lowrance
7:20 – 7:40 Stones and Upper Urinary Obstruction – Thomas Jarrett
7:40 – 8:00 Urinary Adverse Events After Prostatectomy – Jaspreet Sandhu
8:00 – 8:20 When Urodynamics and Symptoms Don’t Match – Kathleen C. Kobashi
8:20 – 8:40 Break with Exhibitors
8:40 – 9:00 Alternative Forms of Testosterone Supplementation: The Role for Selective Estrogen Receptor Modulators and Aromatase Inhibitors – Landon Trost
9:00 – 9:20 Genetic Testing of Prostate Cancer: Will It Change Our Treatment Approach? – Will Lowrance
9:20 – 9:40 Endoscopic Management of Upper Tract Transitional Cell Carcinoma – Thomas Jarrett
9:40 – 10:00 Quality Measures in the US: An Evolution – Timothy Averch 
10:00 – 10:45 Understanding MACRA – Chris Johnson
10:45 – 3:30 Group Discussion “Ad Lib”
3:30 – 4:00 Après ski with Exhibitors
4:00 – 4:20 Female Pelvic Floor Reconstruction: Trials and Tribulations – Jennifer Anger
4:20 – 4:40 Differences of Technology to Improve TURBT for Bladder Cancer – Pierluigi Bove
4:40 – 7:40

Critique Panel Discussion

Friday, February 10th, 2017

AM
6:00 – 7:00 Breakfast with Exhibitors
7:00 – 7:20 Outcomes Assessment: What Should We Be Measuring, Anyway?! – Kathleen C. Kobashi
7:20 – 7:40 Optimizing Urinary Outcomes After Radical Prostatectomy – Jaspreet Sandhu
7:40 – 8:00 Panurothelial Transitional Cell Carcinoma: Lessons Learned – Thomas Jarrett
8:00 – 8:20 Selecting Appropriate Candidates for Penile Prostheses: How to Avoid the CURSED Penis – Landon Trost
8:20 – 8:40 Break with Exhibitors
8:40 – 9:00 Neo Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma (UTUC) – Thomas Jarrett
9:00 – 9:20 The Natural History of Peyronie’s Disease – Landon Trost
9:20 – 9:40 An Overview of Castration Resistant Prostate Cancer – Will Lowrance
9:40 – 10:00 Open Versus Laparascopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-Analysis of Surgical and Oncological Outcomes – Salvatore Micali
10:00 – 11:00 How I do it Round Table: Endourology – Timothy Averch
11:00 – 3:30 Group Discussion “Ad Lib”
3:30 – 4:00 Après ski with Exhibitors
4:00 – 4:20 Prostate Biopsy Strategies – Gerald Andriole
4:20 – 4:40 Transperineal Prostate Needle Biopsy – Roberto Miano
4:40 – 7:40

Critique Panel Discussion

Saturday, February 11th, 2017

AM
6:00 – 7:00 Breakfast with Exhibitors
7:00 – 7:20 Is Re-resection Necessary if the Initial Transurethral Resection of the Bladder Tumor is of High Quality? – Will Lowrance
7:20 – 7:40 Patient Education and Health Literacy Impact on Overactive Bladder Quality of Life – Kathleen C. Kobashi
7:40 – 8:00 Voiding Dysfunction and Urinary Tract Reconstruction After Radical Pelvic Surgery – Jaspreet Sandhu
8:00 – 8:20 Diagnosis and Management of Biochemical Failure After Radiation Therapy – Will Lowrance
8:20 – 8:40 Break with Exhibitors
8:40 – 9:00 Active Surveillance and Focal Ablation for Prostate Cancer – Gerald Andriole
9:00 – 9:20 Buccal Mucosa Graft Urethroplasty After Radiation: an Update – Margit Fisch
9:20 – 9:40 The Era of Digital Ureteroscopy – Wilson Molina
9:40 – 10:00 Nanotechnology for Prostate Cancer – Priya Werahera
10:00 – 11:00 How I do it Round Table:
Challenging Cases of Lower Urinary Tract Reconstruction – Joel Gelman
11:00 – 3:30 Group Discussion “Ad Lib”
3:30 – 4:00 Après ski with Exhibitors
4:00 – 7:00

Critique Panel Discussion

7:00 – 8:00 American Board of Urology Update – Gerry Jordan
8:00 – 9:30 Discussion and Awards Banquet

Sunday, February 12th, 2017

AM
6:00 – 7:00 Breakfast
7:00 – 7:20 TRUS Prostate Needle Biopsy – Chris Porter
7:20 – 9:30 Case Presentation: Patient Safety in Surgery – Timothy Averch and Fernando J. Kim